Mats Wahlstrom - 17 Dec 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director, 10%+ Owner
Signature
/s/ Sean Murphy, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
17 Dec 2024
Net transactions value
+$99,996
Form type
4
Filing time
19 Dec 2024, 18:07:25 UTC
Previous filing
25 Nov 2024
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $99,996 +25,188 +160% $3.97 40,915 17 Dec 2024 Direct F1
holding TLSI Common Stock 1,254,259 17 Dec 2024 By Leonard Capital LLC F2
holding TLSI Common Stock 1,370,028 17 Dec 2024 By HW Investment Partners, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued in connection with the closing of the transaction contemplated by the Securities Purchase Agreement, entered into December 12, 2024, by and between the Issuer and Reporting Person.
F2 The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
F3 The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.